GS71

GSK plc

Stock XETRA – Stock Market Prices, News & Analysis

GSK plc is a global biopharmaceutical company focused on developing vaccines, specialty medicines, and consumer healthcare products.

€ 22.09
5.72 %

GSK plc

22.09
5.72 %
GS71

GSK plc is a global biopharmaceutical company focused on developing vaccines, specialty medicines, and consumer healthcare products.

Price history of GSK plc
Price history of GSK plc

Performance & Momentum

6 Months 28.20 %
1 Year 53.03 %
3 Years 59.52 %
5 Years 84.67 %

Strategic Analysis

GSK plc • 2026

GSK plc is a global biopharmaceutical player that stands out for its balanced portfolio of vaccines, specialty medicines, and consumer health products. This diversification enables the company to capitalize on stable markets while innovating in high-potential therapeutic segments.

Strengths
  • Strong positioning in vaccines with high-value products
  • Balanced diversification between consumer health and biotechnology
  • Global presence allowing access to diverse markets
Weaknesses
  • Exposure to regulatory cycles and risks associated with clinical research
  • Intense competition in the pharmaceutical and vaccine sectors
Momentum

The observed momentum is robust, reflecting a sustainable positive dynamic driven by strong operational results and renewed investor interest. This favorable trend encourages consideration of GSK as a resilient stock in the health sector with enhanced valuation potential.

Similar stocks to GSK plc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone